友善列印 - Tai, C. J.*, H. Wang, C. K. Wang, C. J. Tai, M. T. Huang, C. H. Wu, R. J. Chen, L. J. Kuo, P. L. Wei, Y. J. Chang, C. C. Chang, H. Y. Chiou, and C. J. Wu* (2017) Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic

Tai, C. J., H. Wang, C. K. Wang, C. J. Tai, M. T. Huang, C. H. Wu, R. J. Chen, L. J. Kuo, P. L. Wei, Y. J. Chang, C. C. Chang, H. Y. Chiou, and C. J. Wu (2017) Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic

作者: 吳彰哲

發表年度: 2017

著作類別: 期刊論文

著作名稱: Tai, C. J.*, H. Wang, C. K. Wang, C. J. Tai, M. T. Huang, C. H. Wu, R. J. Chen, L. J. Kuo, P. L. Wei, Y. J. Chang, C. C. Chang, H. Y. Chiou, and C. J. Wu*. Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. Clinical and Experimental Medicine. 17, 141–150, 2017. (SCI, Impact Factor: 5.057, 57/139, MEDICINE, RESEARCH & EXPERIMENTAL)